Smith & Nephew is a global medical technology company that designs and manufactures products for the repair, regeneration, and replacement of soft and hard tissue. Founded in 1856, it is a publicly listed company on both the FTSE 100 and the NYSE, employing over 18,000 people with operations in more than 100 countries. Its headquarters are located in Hull, England.
The company's work spans several technical domains including orthopaedics, sports medicine, advanced wound management, and robotics-assisted surgery. Its portfolio includes products such as the PICO negative pressure wound therapy system, the CORI Surgical System for robotics-assisted surgery, and the REGENETEN Bioinductive Implant. The company states a mission to restore people's bodies and self-belief, focusing on innovative solutions for challenging clinical needs.
As a legal entity operating in Brazil, BRA - Smith & Nephew Comercio de Produtos Medicos LTDA represents the company's presence in the country, distributing and commercializing its medical products within a major emerging market. This local entity is part of a global structure that serves millions of patients annually, working with healthcare professionals across diverse markets and healthcare systems.
